IBI354

· Innovent Biologics (Suzhou) Co. Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for IBI354, covering 2025-03-20 to 2025-04-13. Get the full timeline:

Most recent: Clinical Trial Update: Study of IBI354 Versus Investigator's Choice of Chemotherapy in Patients With Platinum-resistant Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [Phase 3]

See pricing